{
  "DOI": "10.1007/s10689-008-9223-7",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-008-9223-7",
  "alternative-id": [
    "9223"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Hubert",
      "given": "Ayala",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Mali",
      "given": "Bela",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Hamburger",
      "given": "Tamar",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rottenberg",
      "given": "Yakir",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Uziely",
      "given": "Beatrice",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Peretz",
      "given": "Tamar",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kadouri",
      "given": "Luna",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2008,
        11,
        18
      ]
    ],
    "date-time": "2008-11-18T04:19:54Z",
    "timestamp": 1226981994000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T21:45:58Z",
    "timestamp": 1559252758000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        9,
        23
      ]
    ],
    "date-time": "2023-09-23T23:18:51Z",
    "timestamp": 1695511131068
  },
  "is-referenced-by-count": 14,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2008,
        11,
        19
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2009,
          9
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2008,
            11,
            19
          ]
        ],
        "date-time": "2008-11-19T00:00:00Z",
        "timestamp": 1227052800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-008-9223-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-008-9223-7/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-008-9223-7",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "173-177",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2008,
        11,
        19
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2008,
        11,
        19
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2009,
        9
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1002/(SICI)1097-0142(19960215)77:4\u003c697::AID-CNCR16\u003e3.0.CO;2-W",
      "author": "JN Marcus",
      "doi-asserted-by": "crossref",
      "first-page": "697",
      "journal-title": "Cancer",
      "key": "9223_CR1",
      "unstructured": "Marcus JN, Watson P, Page DL et al (1996) Hereditary breast cancer: pathology, prognosis and BRCA1 and BRCA2 gene linkage. Cancer 77:697–709. doi:10.1002/(SICI)1097-0142(19960215)77:4\u003c697::AID-CNCR16\u003e3.0.CO;2-W",
      "volume": "77",
      "year": "1996"
    },
    {
      "DOI": "10.1023/A:1006350518190",
      "author": "U Hamann",
      "doi-asserted-by": "crossref",
      "first-page": "185",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9223_CR2",
      "unstructured": "Hamann U, Sinn HP (2000) Survival and tumor characteristics of German hereditary breast cancer patients. Breast Cancer Res Treat 59:185–192. doi: 10.1023/A:1006350518190",
      "volume": "59",
      "year": "2000"
    },
    {
      "DOI": "10.1056/NEJMoa070608",
      "author": "G Rennert",
      "doi-asserted-by": "crossref",
      "first-page": "115",
      "journal-title": "N Engl J Med",
      "key": "9223_CR3",
      "unstructured": "Rennert G, Bisland-Naggan S, Barnett-Griness O et al (2007) Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 357:115–123. doi: 10.1056/NEJMoa070608",
      "volume": "357",
      "year": "2007"
    },
    {
      "author": "WD Foulkes",
      "first-page": "2465",
      "journal-title": "Clin Cancer Res",
      "key": "9223_CR4",
      "unstructured": "Foulkes WD, Wong N, Brunet JS et al (1997) Germline mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer. Clin Cancer Res 3:2465–2469",
      "volume": "3",
      "year": "1997"
    },
    {
      "DOI": "10.1200/JCO.2000.18.24.4053",
      "author": "D Stoppa-Lyonnet",
      "doi-asserted-by": "crossref",
      "first-page": "4035",
      "journal-title": "J Clin Oncol",
      "key": "9223_CR5",
      "unstructured": "Stoppa-Lyonnet D, Ansquer Y, Dreyfus H et al (2000) Familial invasive breast cancers: worse outcome related to BRCA1 mutations. J Clin Oncol 18:4035–4039",
      "volume": "18",
      "year": "2000"
    },
    {
      "DOI": "10.1186/bcr658",
      "author": "ME Robson",
      "doi-asserted-by": "crossref",
      "first-page": "R8",
      "journal-title": "Breast Cancer Res",
      "key": "9223_CR6",
      "unstructured": "Robson ME, Chappuis PO, Satagopan J et al (2004) A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res 6:R8–R17. doi: 10.1186/bcr658",
      "volume": "6",
      "year": "2004"
    },
    {
      "DOI": "10.1001/jama.283.17.2260",
      "author": "D Boyd",
      "doi-asserted-by": "crossref",
      "first-page": "2260",
      "journal-title": "J Am Med Assoc",
      "key": "9223_CR7",
      "unstructured": "Boyd D, Somoda Y, Federici MG et al (2000) Clinicopathologic features of BRCA linked and sporadic ovarian cancer. J Am Med Assoc 283:2260–2265. doi: 10.1001/jama.283.17.2260",
      "volume": "283",
      "year": "2000"
    },
    {
      "DOI": "10.1093/aje/152.6.528",
      "author": "V McGuire",
      "doi-asserted-by": "crossref",
      "first-page": "528",
      "journal-title": "Am J Epidemiol",
      "key": "9223_CR8",
      "unstructured": "McGuire V, Whitmore AS, Norris R, Oakley-Girvan I (2000) Survival in epithelial ovarian cancer patients with prior breast cancer. Am J Epidemiol 152:528–532. doi: 10.1093/aje/152.6.528",
      "volume": "152",
      "year": "2000"
    },
    {
      "DOI": "10.1200/JCO.2002.20.2.463",
      "author": "Y Ben David",
      "doi-asserted-by": "crossref",
      "first-page": "463",
      "journal-title": "J Clin Oncol",
      "key": "9223_CR9",
      "unstructured": "Ben David Y, Chetrit A, Hirsh-Yechezkel G et al (2003) Effect of BRCA mutations on the length of survival in epithelial ovarian tumors. J Clin Oncol 20:463–466. doi: 10.1200/JCO.20.2.463",
      "volume": "20",
      "year": "2003"
    },
    {
      "DOI": "10.1007/s10689-005-2832-5",
      "author": "DF Foulkes",
      "doi-asserted-by": "crossref",
      "first-page": "135",
      "journal-title": "Fam Cancer",
      "key": "9223_CR10",
      "unstructured": "Foulkes DF (2006) BRCA1 and BRCA2: chemosensitivity, treatment outcomes and prognosis. Fam Cancer 5:135–142. doi: 10.1007/s10689-005-2832-5",
      "volume": "5",
      "year": "2006"
    },
    {
      "DOI": "10.1093/jnci/90.15.1138",
      "author": "SR Lakhani",
      "doi-asserted-by": "crossref",
      "first-page": "1138",
      "journal-title": "J Natl Cancer Inst",
      "key": "9223_CR11",
      "unstructured": "Lakhani SR, Jacquemier J, Sloane JP et al (1998) Multifactortial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90:1138–1145. doi: 10.1093/jnci/90.15.1138",
      "volume": "90",
      "year": "1998"
    },
    {
      "DOI": "10.1006/gyno.2002.6646",
      "author": "DA Levine",
      "doi-asserted-by": "crossref",
      "first-page": "431",
      "journal-title": "Gynecol Oncol",
      "key": "9223_CR12",
      "unstructured": "Levine DA, Federici MG, Reuter VE, Boyd J (2002) Cell proliferation and apoptosis in BRCA-associated hereditary ovarian cancer. Gynecol Oncol 85:431–434. doi: 10.1006/gyno.2002.6646",
      "volume": "85",
      "year": "2002"
    },
    {
      "DOI": "10.1002/cncr.11688",
      "author": "WD Foulkes",
      "doi-asserted-by": "crossref",
      "first-page": "1569",
      "issue": "8",
      "journal-title": "Cancer",
      "key": "9223_CR13",
      "unstructured": "Foulkes WD, Metcalfe K, Hanna W et al (2003) Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer 98(8):1569–1577. doi: 10.1002/cncr.11688",
      "volume": "98",
      "year": "2003"
    },
    {
      "DOI": "10.1136/jmg.39.8.608",
      "author": "DO Chappuis",
      "doi-asserted-by": "crossref",
      "first-page": "608",
      "journal-title": "J Med Genet",
      "key": "9223_CR14",
      "unstructured": "Chappuis DO, Goffin J, Wong N, Perret C (2002) A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer. J Med Genet 39:608–610. doi: 10.1136/jmg.39.8.608",
      "volume": "39",
      "year": "2002"
    },
    {
      "key": "9223_CR15",
      "unstructured": "Delaloge S, Pelissier P, Kloos I et al (2002) BRCA1 linked breast cancer is highly more chemosensitive than its BRCA2-linked or sporadic counterparts. 27th ESMO, Niece, France, Abstract no. 120"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-04-2421",
      "author": "R Rouzier",
      "doi-asserted-by": "crossref",
      "first-page": "5678",
      "issue": "16",
      "journal-title": "Clin Cancer Res",
      "key": "9223_CR16",
      "unstructured": "Rouzier R, Perou CM, Symmans WF et al (2005) Breat cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11(16):5678–5685. doi: 10.1158/1078-0432.CCR-04-2421",
      "volume": "11",
      "year": "2005"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-06-1109",
      "author": "LA Carey",
      "doi-asserted-by": "crossref",
      "first-page": "2329",
      "issue": "8",
      "journal-title": "Clin Cancer Res",
      "key": "9223_CR17",
      "unstructured": "Carey LA, Dees EC, Sawyer L et al (2007) The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 13(8):2329–2334. doi: 10.1158/1078-0432.CCR-06-1109",
      "volume": "13",
      "year": "2007"
    },
    {
      "DOI": "10.1200/JCO.2007.14.4147",
      "author": "C Liedtke",
      "doi-asserted-by": "crossref",
      "first-page": "1275",
      "issue": "8",
      "journal-title": "J Clin Oncol",
      "key": "9223_CR18",
      "unstructured": "Liedtke C, Mazouni C, Hess KR et al (2008) Response to neoadjuvant chemotherapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol 26(8):1275–1281. doi: 10.1200/JCO.2007.14.4147",
      "volume": "26",
      "year": "2008"
    },
    {
      "DOI": "10.1007/PL00002414",
      "doi-asserted-by": "crossref",
      "key": "9223_CR19",
      "unstructured": "Bremer M, Steinmann D, Dork T, Borger J, Rades D, Karstens JH (2001) Bilateral breast carcinoma and local recurrence: prevalence of BRCA-1 and BRCA-2 gene mutations in an unselected patient sample. Strahlenther Onkol 177:325–329. German. doi: 10.1007/PL00002414"
    },
    {
      "DOI": "10.1128/MCB.22.12.4280-4292.2002",
      "author": "TK MacLachlan",
      "doi-asserted-by": "crossref",
      "first-page": "4280",
      "journal-title": "Mol Cell Biol",
      "key": "9223_CR20",
      "unstructured": "MacLachlan TK, Takimor R, El-Deiry WS (2002) BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets. Mol Cell Biol 22:4280–4292. doi: 10.1128/MCB.22.12.4280-4292.2002",
      "volume": "22",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.yexcr.2004.05.004",
      "author": "M Fabbro",
      "doi-asserted-by": "crossref",
      "first-page": "661",
      "journal-title": "Exp Cell Res",
      "key": "9223_CR21",
      "unstructured": "Fabbro M, Schuechner S, Av WW, Henderson BR (2004) BARD1 regulates BRCA1 apoptosis function by a mechanism involving nuclear retention. Exp Cell Res 298:661–673. doi: 10.1016/j.yexcr.2004.05.004",
      "volume": "298",
      "year": "2004"
    },
    {
      "author": "MS Greenblatt",
      "first-page": "4092",
      "journal-title": "Cancer Res",
      "key": "9223_CR22",
      "unstructured": "Greenblatt MS, Chappuis PO, Bond JP et al (2001) TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germline mutations: distinctive spectrum and structural distributions. Cancer Res 61:4092–4097",
      "volume": "61",
      "year": "2001"
    },
    {
      "author": "RE Buller",
      "first-page": "831",
      "journal-title": "Clin Cancer Res",
      "key": "9223_CR23",
      "unstructured": "Buller RE, Lallas TA, Shahin MS et al (2001) The P53 mutation spectrum associated with BRCA1 mutation ovarian cancer. Clin Cancer Res 7:831–838",
      "volume": "7",
      "year": "2001"
    },
    {
      "DOI": "10.1038/ng.2007.39",
      "author": "L Saal",
      "doi-asserted-by": "crossref",
      "first-page": "102",
      "issue": "1",
      "journal-title": "Nat Genet",
      "key": "9223_CR24",
      "unstructured": "Saal L, Grunberger-Saal SK, Persson C et al (2008) Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers deficient DSB repair. Nat Genet 40(1):102–107. doi: 10.1038/ng.2007.39",
      "volume": "40",
      "year": "2008"
    }
  ],
  "reference-count": 24,
  "references-count": 24,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-008-9223-7"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Response to neo-adjuvant chemotherapy in BRCA1 and BRCA2 related stage III breast cancer"
  ],
  "type": "journal-article",
  "volume": "8"
}